GEN Exclusives

More »

GEN News Highlights

More »
Feb 6, 2007

KineMed and Bayer Healthcare to Discover New Therapeutic Applications for Candidates

  • KineMed and Bayer Healthcare signed an agreement to discover new therapeutic applications. "The collaboration with Bayer Healthcare is an important opportunity for us to discover new indications for promising compounds and to work with Bayer Healthcare to pursue clinical development,” comments David Fineman, president and CEO of KineMed.

    KineMed will identify new therapeutic utilities by applying its translational medicine technologies, AquaTag™ and KineMarker™. Once a disease target is established for a selected drug candidate, the companies will jointly determine the best development and commercialization path.

    “This is in fact,” points out Finemen, “the third indications discovery deal we have announced in the past year, each of which gives us the option to move into more advanced product development."



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?